I saw your advert in the paper silverdaddies.com A federal advisory panel recommended approval ofGlaxoSmithKline’s new drug to treat chronic obstructivepulmonary disease (COPD), but suggested the company be requiredto conduct further safety studies once the drug is approved. GSKis developing the product with Theravance.